Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11702469 Recombinant EGFL7, EGFL7 antibodies, and uses thereof
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 4 Apr, 2024
"update inverses"
Golden AI
edited on 4 Apr, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11945785 Pyrazine compounds as inhibitors of FLT3
0
Edits on 19 Jul, 2023
"Created via: Entity Importer"
Golden AI
created this topic on 19 Jul, 2023
Edits made to:
Infobox
(
+25
properties)
Article
(
+88
characters)
US Patent 11702469 Recombinant EGFL7, EGFL7 antibodies, and uses thereof
Article
The present disclosure relates to recombinant EGFL7, EGFL7 antibodies, and uses thereof.
Infobox
Is a
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11702469
0
Date of Patent
July 18, 2023
0
Patent Application Number
16607930
0
Date Filed
April 24, 2018
0
Patent Citations
US Patent 8398976 Antibodies to EGFL7 and methods for their use
0
US Patent 8574576 Humanized anti-EGFL7 antibodies and methods using same
0
Patent Primary Examiner
Hong Sang
0
CPC Code
C12N 2310/113
0
C12N 15/113
0
C12N 5/0647
0
C07K 16/22
0
A61K 31/136
0
A61K 45/06
0
A61K 39/395
0
A61P 35/00
0
A61P 35/02
0
A61K 31/7076
0
A61K 31/7068
0
A61K 31/7048
0
A61K 31/704
0
A61K 31/5377
0
A61K 31/475
0
A61K 31/4745
0
Find more entities like US Patent 11702469 Recombinant EGFL7, EGFL7 antibodies, and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE